December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Visual Fields in Successfully Treated Retinoblastoma Patients
Author Affiliations & Notes
  • MR Melson
    School of Medicine University of Virginia Charlottesville VA
  • C Servodidio
    Hartford Hospital Hartford CT
  • DH Abramson
    Ophthalmology New York Presbyterian Hospital - Weill Medical College of Cornell University New York NY
  • Footnotes
    Commercial Relationships   M.R. Melson, None; C. Servodidio, None; D.H. Abramson, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2589. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      MR Melson, C Servodidio, DH Abramson; Visual Fields in Successfully Treated Retinoblastoma Patients . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2589.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To describe the visual field defects in retinoblastoma survivors and relate those defects to characteristics such as tumor size, tumor location, and treatment modality. Method: Thirty-one retinoblastoma patients treated at the Ophthalmic Oncology Center at New York Presbyterian Hospital, New York Weill Cornell Medical Center were included in this study. Humphrey's Visual Fields were performed on 33 eyes in all 31 patients. Results: Twenty-seven patients (29 eyes, 68 tumors) had sufficient diagnosis and treatment data available for further analysis. Twenty-six of the 27 patients had both absolute and relative visual field defects. Twenty patients had defects within the central 30 degrees of the visual field. Nineteen patients had defects within the peripheral 30-60 degrees. Sixteen patients had defects in both the central 30 degrees and peripheral 30-60 degrees. Twenty tumors produced defects that were larger than predicted based on tumor size alone. Nineteen patients had an enlarged brow/nose defect. An enlarged brow/nose defect was defined as a nasal defect extending greater than 10 degrees nasally and a superior defect extending greater than 20 degrees superiorly. All 27 patients had either absolute or relative defects that crossed the vertical meridian. Twenty-three of the 27 patients had defects that crossed the horizontal meridian. Four patients had an arcuate visual field defect. Conclusion: Retinoblastoma patients demonstrate a variety of long-term visual field defects following treatment for their primary disease. Characteristics that determine the size and type of defects are tumor size, tumor location, and treatment method.

Keywords: 569 retinoblastoma • 624 visual fields • 610 tumors 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.